Passive Dividend

Schwab International Dividend Equity ETF

​ The fund’s goal is to track as closely as possible, before fees and expenses, the total return of an index composed of high dividend yielding stocks issued by companies outside the United States.

$32.07

Key Metrics

TER 0.08% per year
Distribution policy Distributing
Fund size USD 2,250 M
Inception date April 29, 2021
Holdings 105
Fund currency USD
Fund domicile US
Provider Schwab
For full official fund details, factsheets, and holdings, visit schwabassetmanagement.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Schwab International Dividend Equity ETF SCHY
Fund Size
$2.26B
Dividend
3.5%
Fees
0.08%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
0.04%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.1%
Fees
0.03%
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
1.0%
Fees
-
View 1339 similar ETFs →

Historical Return

Last updated: Jul 01, 2026
1 Year +15.7% +3.5% Div
3 Years (avg.) +9.6% +3.5% Div
5 Years (avg.) +4.3% +3.5% Div

Risk & Analysis Metrics

Last updated: Jul 01, 2026

Volatility

11.53% 1 Year
12.28% 3 Years
13.33% 5 Years
13.27% 10 Years

Max Drawdown

-9.25% 1 Year
-13.64% 3 Years
-25.20% 5 Years
-25.42% 10 Years

Sharpe Ratio

0.82 1 Year
0.42 3 Years
0.05 5 Years
0.08 10 Years

Return Triangle (Heatmap)

Last updated: Jul 01, 2026
2021 2022 2023 2024 2025
2021 2.3% -5.7% -1.0% -2.1% 3.4%
2022 -13.0% -2.5% -3.5% 3.7%
2023 9.2% 1.6% 10.0%
2024 -5.5% 10.3%
2025 28.8%

Distributions

*by ETF Portfolio Weight Last updated: Jul 01, 2026

Profit Margin Distribution

< 0%
5%
1y 3y N/A N/A
0 - 5%
16%
1y 3y N/A N/A
5 - 10%
26%
1y 3y N/A N/A
10 - 15%
15%
1y 3y N/A N/A
15 - 20%
12%
1y 3y N/A N/A
20 - 30%
26%
1y 3y N/A N/A
30 - 40%
0%
1y 3y N/A N/A
> 40%
0%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
5%
1y 3y N/A N/A
0 - 10
4%
1y 3y N/A N/A
10 - 15
31%
1y 3y N/A N/A
15 - 20
26%
1y 3y N/A N/A
20 - 25
13%
1y 3y N/A N/A
25 - 35
20%
1y 3y N/A N/A
35 - 50
0%
1y 3y N/A N/A
> 50
0%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.0%
1y 3y N/A N/A
Large Cap
76.9%
1y 3y N/A N/A
Mega Cap
23.1%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jul 01, 2026
47.0% Top 5 Holdings
79.5% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
BHP BHP Group Limited
11.2%
RHHVF Roche Holding AG
9.2%
GSK Glaxosmithkline plc
9.2%
TTE TotalEnergies SE
9.1%
UL Unilever Plc
8.4%

Latest News

24 days ago • wsj.com

After shedding its cancer business just over a decade ago, GSK's new CEO is building back with a $10.6 billion deal

After shedding its oncology business just over a decade ago, GSK is building it back with a $10.6 billion deal.
24 days ago • zacks.com

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study

Gilead and Merck report positive phase III results for once-weekly HIV regimen islatravir/lenacapavir, while ending a lung cancer study.
24 days ago • zacks.com

GSK to Strengthen Oncology Pipeline With $10.6B Nuvalent Buyout

GSK buys Nuvalent for $10.6 billion, adding three lung cancer pipeline candidates and expanding its precision oncology presence.

Average metrics of all companies in portfolio

Last updated: Jun 28, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $139B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 3.73% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.43 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 18.05 28.61
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything - -
Profitable Companies 100% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 21.96 18.04
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 1.59 8.09
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.6 10.18
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 9.97 20.33
Enterprise Value to Revenue Enterprise value divided by revenue 1.94 7.98
Total Debt to Enterprise Value Total debt divided by enterprise value 0.28 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.09 0.27
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 11.77% 20.81%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +3.4% -118.0%
Return on Equity Equity divided by market cap. 32.86% 2.67%
Return on Assets Indicates a company's profitability in relation to its total assets. 9.74% 4.17%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 21.19% 3.72%

Sectors

Mining, Quarrying, and Oil and Gas Extraction 8.4%
Consumer Non-Durables 7.5%
Finance and Insurance 6.4%
Manufacturing 4.8%
Health Technology 4.2%
Information 4.2%
Energy 4.1%
Transportation and Warehousing 3.7%
Communications 2.2%
Other 54.6%

Countries

United Kingdom 14.8%
Australia 10.1%
Switzerland 9.7%
United States 8.9%
Italy 7.6%
France 5.8%
Germany 5.1%
Other 4.8%
Singapore 4.4%
India 4.1%
Canada 4.0%
Netherlands 3.2%
Finland 2.8%
Japan 2.5%
Sweden 2.5%
China 1.7%
Brazil 1.6%
Spain 1.6%
Ireland 0.9%
Bermuda 0.7%
Mexico 0.7%
South Africa 0.6%
Qatar 0.6%
Kuwait 0.3%
Hong Kong 0.3%
Indonesia 0.3%
Denmark 0.1%
Korea (the Republic of) 0.1%
United Arab Emirates 0.1%
Taiwan (Province of China) 0.1%
Norway 0.1%

Stock Screener

Select filters to narrow down the 21 investments below

21 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

BHP Group Limited - ADR

BHP - Mining, Quarrying, and Oil and Gas Extraction

BHP Group Limited - ADR

BHP - Mining, Quarrying, and Oil and Gas Extraction
Market Cap $205.82B
P/E Ratio 20.0
Dividends 3.3%
Total Investment $113.93M
Weight 5.06%

Loading details…

Roche Holding AG

RHHVF - Health Technology

Roche Holding AG

RHHVF - Health Technology
Market Cap $333.25B
P/E Ratio 20.8
Dividends 2.9%
Total Investment $94.43M
Weight 4.20%

Loading details…

GSK Plc - ADR

GSK - Manufacturing

GSK Plc - ADR

GSK - Manufacturing
Market Cap $105.2B
P/E Ratio 13.7
Dividends 3.4%
Total Investment $93.94M
Weight 4.18%

Loading details…

TotalEnergies SE - ADR

TTE - Energy

TotalEnergies SE - ADR

TTE - Energy
Market Cap $170.97B
P/E Ratio 11.4
Dividends 5.0%
Total Investment $92.65M
Weight 4.12%

Loading details…

Unilever plc - ADR

UL - Consumer Non-Durables

Unilever plc - ADR

UL - Consumer Non-Durables
Market Cap $130.45B
P/E Ratio 28.2
Dividends 3.7%
Total Investment $85.43M
Weight 3.80%

Loading details…

British American Tobacco Plc - ADR

BTI - Consumer Non-Durables

British American Tobacco Plc - ADR

BTI - Consumer Non-Durables
Market Cap $135.96B
P/E Ratio 13.5
Dividends 5.1%
Total Investment $83.61M
Weight 3.72%

Loading details…

Deutsche Post AG - ADR

DPSGY - Transportation and Warehousing

Deutsche Post AG - ADR

DPSGY - Transportation and Warehousing
Market Cap $59.13B
P/E Ratio 16.7
Dividends 3.6%
Total Investment $82.79M
Weight 3.68%

Loading details…

Eni Spa - ADR

E - Mining, Quarrying, and Oil and Gas Extraction

Eni Spa - ADR

E - Mining, Quarrying, and Oil and Gas Extraction
Market Cap $67.41B
P/E Ratio 25.3
Dividends 5.2%
Total Investment $74.84M
Weight 3.33%

Loading details…

Vodafone Group plc - ADR

VOD - Communications

Vodafone Group plc - ADR

VOD - Communications
Market Cap $32.01B
P/E Ratio -6213.7
Dividends 3.8%
Total Investment $49.05M
Weight 2.18%

Loading details…

Swisscom AG - ADR

SCMWY - Information

Swisscom AG - ADR

SCMWY - Information
Market Cap $40.93B
P/E Ratio 26.8
Dividends 4.1%
Total Investment $41.57M
Weight 1.85%

Loading details…

Koninklijke KPN NV - ADR

KKPNY - Information

Koninklijke KPN NV - ADR

KKPNY - Information
Market Cap $20.04B
P/E Ratio 20.5
Dividends 4.1%
Total Investment $38.08M
Weight 1.69%

Loading details…

Zurich Insurance Group AG Ltd - ADR

ZURVY - Finance and Insurance

Zurich Insurance Group AG Ltd - ADR

ZURVY - Finance and Insurance
Market Cap $108.53B
P/E Ratio 12.6
Dividends 5.1%
Total Investment $30.91M
Weight 1.37%

Loading details…

China Construction Bank Corp. - ADR

CICHY - Finance and Insurance

China Construction Bank Corp. - ADR

CICHY - Finance and Insurance
Market Cap $370.24B
P/E Ratio 7.5
Dividends 4.0%
Total Investment $27.42M
Weight 1.22%

Loading details…

Bank Of Nova Scotia

BNS - Finance and Insurance

Bank Of Nova Scotia

BNS - Finance and Insurance
Market Cap $105.64B
P/E Ratio 16.8
Dividends 3.6%
Total Investment $23.74M
Weight 1.06%

Loading details…

DBS Group Holdings Ltd - ADR

DBSDY - Finance and Insurance

DBS Group Holdings Ltd - ADR

DBSDY - Finance and Insurance
Market Cap $143.87B
P/E Ratio 17.0
Dividends 4.8%
Total Investment $23.69M
Weight 1.05%

Loading details…

Manulife Financial Corp.

MFC - Finance and Insurance

Manulife Financial Corp.

MFC - Finance and Insurance
Market Cap $67.24B
P/E Ratio 16.3
Dividends 3.2%
Total Investment $14.64M
Weight 0.65%

Loading details…

BCE Inc

BCE - Information

BCE Inc

BCE - Information
Market Cap $21.37B
P/E Ratio 4.8
Dividends 5.4%
Total Investment $14.58M
Weight 0.65%

Loading details…

Itau Unibanco Holding S.A. - ADR

ITUB - Finance and Insurance

Itau Unibanco Holding S.A. - ADR

ITUB - Finance and Insurance
Market Cap $90.71B
P/E Ratio 10.1
Dividends 7.9%
Total Investment $12.17M
Weight 0.54%

Loading details…

Sun Life Financial, Inc.

SLF - Finance and Insurance

Sun Life Financial, Inc.

SLF - Finance and Insurance
Market Cap $43.16B
P/E Ratio 20.5
Dividends 3.3%
Total Investment $10.36M
Weight 0.46%

Loading details…

Ambev S.A. - ADR

ABEV - Manufacturing

Ambev S.A. - ADR

ABEV - Manufacturing
Market Cap $50.38B
P/E Ratio 16.9
Dividends 8.9%
Total Investment $9.18M
Weight 0.41%

Loading details…